Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Nov 15;293(6557):1268–1271. doi: 10.1136/bmj.293.6557.1268

Psychological impact of adjuvant chemotherapy in the first two years after mastectomy.

A V Hughson, A F Cooper, C S McArdle, D C Smith
PMCID: PMC1342107  PMID: 3535990

Abstract

Psychological symptoms were assessed over two years in a randomised trial of three forms of treatment given to women after mastectomy for stage II breast cancer. The treatments were: three weeks' radiotherapy; one year's adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil; and radiotherapy followed by chemotherapy. Analysis of the results on an intention to treat basis showed no substantial differences in depression or anxiety among groups at one, three, or six months after the operation. At 13 months, however, patients who had been allocated chemotherapy had significantly more symptoms, especially depression, than control patients treated with radiotherapy alone. Conditioned reflex nausea and vomiting increased considerably during the second six months of chemotherapy and persisted for up to a year afterwards. The psychological morbidity of adjuvant chemotherapy could be substantially reduced if courses of treatment were restricted to about six months.

Full text

PDF
1269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum M., Priestman T., West R. R., Jones E. M. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer. 1980;Suppl 1:223–226. [PubMed] [Google Scholar]
  2. Bonadonna G., Brusamolino E., Valagussa P., Rossi A., Brugnatelli L., Brambilla C., De Lena M., Tancini G., Bajetta E., Musumeci R. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976 Feb 19;294(8):405–410. doi: 10.1056/NEJM197602192940801. [DOI] [PubMed] [Google Scholar]
  3. Bonadonna G., Valagussa P., Rossi A., Tancini G., Brambilla C., Zambetti M., Veronesi U. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat. 1985;5(2):95–115. doi: 10.1007/BF01805984. [DOI] [PubMed] [Google Scholar]
  4. Howell A., Bush H., George W. D., Howat J. M., Crowther D., Sellwood R. A., Rubens R. D., Hayward J. L., Bulbrook R. D., Fentiman I. S. Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet. 1984 Aug 11;2(8398):307–311. doi: 10.1016/s0140-6736(84)92684-9. [DOI] [PubMed] [Google Scholar]
  5. Maguire G. P., Lee E. G., Bevington D. J., Küchemann C. S., Crabtree R. J., Cornell C. E. Psychiatric problems in the first year after mastectomy. Br Med J. 1978 Apr 15;1(6118):963–965. doi: 10.1136/bmj.1.6118.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Maguire P., Tait A., Brooke M., Thomas C., Sellwood R. Effect of counselling on the psychiatric morbidity associated with mastectomy. Br Med J. 1980 Nov 29;281(6253):1454–1456. doi: 10.1136/bmj.281.6253.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Meyerowitz B. E., Sparks F. C., Spears I. K. Adjuvant chemotherapy for breast carcinoma: psychosocial implications. Cancer. 1979 May;43(5):1613–1618. doi: 10.1002/1097-0142(197905)43:5<1613::aid-cncr2820430508>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  8. Meyerowitz B. E., Watkins I. K., Sparks F. C. Psychosocial implications of adjuvant chemotherapy. A two-year follow-up. Cancer. 1983 Oct 15;52(8):1541–1545. doi: 10.1002/1097-0142(19831015)52:8<1541::aid-cncr2820520834>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  9. Morris T. Psychological adjustment to mastectomy. Cancer Treat Rev. 1979 Mar;6(1):41–61. doi: 10.1016/s0305-7372(79)80058-4. [DOI] [PubMed] [Google Scholar]
  11. Palmer B. V., Walsh G. A., McKinna J. A., Greening W. P. Adjuvant chemotherapy for breast cancer: side effects and quality of life. Br Med J. 1980 Dec 13;281(6255):1594–1597. doi: 10.1136/bmj.281.6255.1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Redd W. H. Control of nausea and vomiting in chemotherapy patients. Four effective behavioral methods. Postgrad Med. 1984 Apr;75(5):105-7, 110-3. doi: 10.1080/00325481.1984.11697994. [DOI] [PubMed] [Google Scholar]
  13. Selby P. Measurement of the quality of life after cancer treatment. Br J Hosp Med. 1985 May;33(5):266–271. [PubMed] [Google Scholar]
  14. Silberfarb P. M., Maurer L. H., Crouthamel C. S. Psychosocial aspects of neoplastic disease: I. Functional status of breast cancer patients during different treatment regimens. Am J Psychiatry. 1980 Apr;137(4):450–455. doi: 10.1176/ajp.137.4.450. [DOI] [PubMed] [Google Scholar]
  15. Snaith R. P., Bridge G. W., Hamilton M. The Leeds scales for the self-assessment of anxiety and depression. Br J Psychiatry. 1976 Feb;128:156–165. doi: 10.1192/bjp.128.2.156. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES